Cell Medica begins production in Germany; Novasep inks $5.3M deal with Celladon; SGS rolls out new amino acid test;

> Cell Medica, a cellular immunotherapy company based in the U.K. has begun commercial cell therapy manufacturing at its facility at the Max-Delbrück-Centre of Molecular Medicine in Berlin-Buch, Germany. Story

> Novasep has given the green light to a $5.3 million deal with Celladon, a clinical-stage biotechnology company, to supply the drug substance for Mydicar. Article

> Swiss-based SGS has rolled out a new and more sensitive amino acid impurities test at its facilities in Germany. Report

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.